Measurement of radionuclide spatial and temporal distribution and dose calculation for in vitro assessments of 212Pb-αVCAM-1 targeted alpha therapy

A.M. Frelin-Labalme (1) , T. Roger (1) , N Falzone (2, 3) , B Quan Lee (2, 3) , Nr Sibson (2) , Ka Vallis (2) , Myriam Bernaudin (4) , S Valable (4) , A Corroyer-Dulmont (4)

1 GANIL - Grand Accélérateur National d'Ions Lourds
2 CRUK/MRC - Department of Oncology [Oxford, UK]
3 GenesisCare
4 ISTCT - Imagerie et Stratégies Thérapeutiques des pathologies Cérébrales et Tumorales

Domaines: Sciences du Vivant [q-bio]; Physique Médicale [physics.med-ph]

A.M. Frelin-Labalme, T. Roger, N Falzone, B Quan Lee, Nr Sibson, et al.. Measurement of radionuclide spatial and temporal distribution and dose calculation for in vitro assessments of 212Pb-αVCAM-1 targeted alpha therapy. 4th Nuclear Technologies for Health Symposium, NTHS 2020, Feb 2020, Nantes, France. ⟨hal-02488871⟩